Clene Inc. (CLNN) stock
CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.42+0.20 (+6.21%)
Close on Nov 18, 2026Market cap $43.94MP/E –Yield –
Clene shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Clene's shares outstanding was 12M at Jun 30, 2026. For fiscal 2025 it was 10M, up 41.8% from the year before. The highest annual figure on record is 10M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10M | +41.8% |
| FY2024 | Dec 31, 2024 | 7M | +32.5% |
| FY2023 | Dec 31, 2023 | 5M | +60.9% |
| FY2022 | Dec 31, 2022 | 3M | +5.9% |
| FY2021 | Dec 31, 2021 | 3M | +251.7% |
| FY2020 | Dec 31, 2020 | 1M | +0.8% |
| FY2019 | Dec 31, 2019 | 1M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 12M | +30.0% |
| Q1 FY2026 | Mar 31, 2026 | 12M | +32.0% |
| Q4 FY2025 | Dec 31, 2025 | 11M | +28.2% |
| Q3 FY2025 | Sep 30, 2025 | 10M | +56.8% |
| Q2 FY2025 | Jun 30, 2025 | 10M | +48.3% |
| Q1 FY2025 | Mar 31, 2025 | 9M | +37.4% |
| Q4 FY2024 | Dec 31, 2024 | 8M | +30.8% |
| Q3 FY2024 | Sep 30, 2024 | 7M | +2.1% |
| Q2 FY2024 | Jun 30, 2024 | 6M | +49.3% |
| Q1 FY2024 | Mar 31, 2024 | 6M | +68.9% |
| Q4 FY2023 | Dec 31, 2023 | 6M | +103.2% |
| Q3 FY2023 | Sep 30, 2023 | 6M | +104.3% |
| Q2 FY2023 | Jun 30, 2023 | 4M | +38.1% |
| Q1 FY2023 | Mar 31, 2023 | 4M | +8.6% |
| Q2 FY2022 | Jun 30, 2022 | 3M | +3.5% |
| Q1 FY2022 | Mar 31, 2022 | 3M | +3.6% |
| Q4 FY2021 | Dec 31, 2021 | 3M | +247.3% |
| Q3 FY2021 | Sep 30, 2021 | 4M | +303.5% |
| Q2 FY2021 | Jun 30, 2021 | 3M | +252.4% |
| Q1 FY2021 | Mar 31, 2021 | 3M | +249.5% |
| Q4 FY2020 | Dec 31, 2020 | 1M | – |
| Q3 FY2020 | Sep 30, 2020 | 1M | – |
| Q2 FY2020 | Jun 30, 2020 | 1M | – |
| Q1 FY2020 | Mar 31, 2020 | 1M | – |
See a number that looks wrong?